true test plaster til provokationstest
smartpractice denmark aps - alfa-amylcinnamaldehyd, almindelig slåenlav (evernia prunastri), benzocain, benzylparahydroxybenzoat, butylparahydroxybenzoat, chlorquinaldol, cinchocainhydrochlorid, cinnamaldehyd, cinnamylalkohol, clioquinol, cyclohexylbenzothiazylsulfenamid, dibenzothiazyldisulfid, dipentamethylenthiuramdisulfid, diphenylguanidin, disulfiram, epoxyresin, ethylendiamindihydrochlorid, ethylparahydroxybenzoat, eugenol, geraniol, hydroxycitronellal, isoeugenol, kaliumdichromat, koboltchlorid, kolofonium, lanolinalkohol, merc - plaster til provokationstest
dolmatil 400 mg filmovertrukne tabletter
orifarm a/s - sulpirid - filmovertrukne tabletter - 400 mg
soliris
alexion europe sas - eculizumab - hemoglobinuri, paroxysmal - immunosuppressiva - soliris er indiceret hos voksne og børn til behandling af:paroksysmal natlig haemoglobinuria (pnh). dokumentation af klinisk fordel er påvist hos patienter med haemolysis med klinisk symptom(er) betegnende for høj sygdomsaktivitet, uanset transfusion historie (se afsnit 5. atypiske hæmolytisk uræmisk syndrom (ahus). soliris er indiceret hos voksne til behandling af:ildfaste generaliseret myasthenia gravis (gmg) i patienter, der er anti-acetylcholin-receptor (achr) antistof-positive (se afsnit 5. neuromyelitis optica spektrum forstyrrelse (nmosd) i patienter, der er anti-aquaporin-4 (aqp4) antistof-positive med en recidiverende forløbet af sygdommen.
supemtek
sanofi pasteur - influenza a virus subtype h1n1 haemagglutinin, recombinant, influenza a virus subtype h3n2 haemagglutinin, recombinant, influenza b virus victoria lineage haemagglutinin, recombinant, influenza b virus yamagata lineage haemagglutinin, recombinant - influenza, human - vacciner - supemtek is indicated for active immunization for the prevention of influenza disease in adults. supemtek should be used in accordance with official recommendations.
epysqli
samsung bioepis nl b.v. - eculizumab - hemoglobinuri, paroxysmal - immunosuppressiva - epysqli is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). evidence of clinical benefit is demonstrated in patients with haemolysis with clinical symptom(s) indicative of high disease activity, regardless of transfusion history.
bekemv
amgen technology (ireland) uc - eculizumab - hemoglobinuri, paroxysmal - immunosuppressiva - bekemv is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). dokumentation af klinisk fordel er påvist hos patienter med haemolysis med klinisk symptom(er) betegnende for høj sygdomsaktivitet, uanset transfusion historie (se afsnit 5.
campral 333 mg enterotabletter
merck sante s.a.s. - acamprosatcalcium - enterotabletter - 333 mg
campral 333 mg enterotabletter
paranova danmark a/s - acamprosatcalcium - enterotabletter - 333 mg
campral 333 mg enterotabletter
orifarm a/s - acamprosatcalcium - enterotabletter - 333 mg
campral ec 333 mg enterotabletter
orifarm a/s - acamprosatcalcium - enterotabletter - 333 mg